Patent assignee · DE · COMPANY

CureVac SE

🏢 View company profile →
55Patents
53Active
55Granted
64Portfolio score

Filing activity: May 13, 2016 → Aug 12, 2024

Most-cited patents

PatentTitleAreaCited byStatus
US11576966B2 Coronavirus vaccine Chemistry; Metallurgy 13 Active
US11596686B2 Coronavirus vaccine Chemistry; Metallurgy 13 Active
US11596699B2 RNA encoding an antibody Emerging Cross-Sectional Technologies 8 Active
US11602557B2 Bunyavirales vaccine Emerging Cross-Sectional Technologies 8 Active
US11542490B2 RNAs for wound healing Chemistry; Metallurgy 7 Active
US11525158B2 Linear double stranded DNA coupled to a single support or a tag and methods for producing said linear double stranded DNA Chemistry; Metallurgy 7 Active
US11524066B2 Henipavirus vaccine Chemistry; Metallurgy 7 Active
US11559570B2 Prime-boost regimens involving administration of at least one mRNA construct Emerging Cross-Sectional Technologies 7 Active
US11739125B2 Respiratory syncytial virus (RSV) vaccine Chemistry; Metallurgy 6 Active
US11608513B2 Method for adding cap structures to RNA using immobilized enzymes Chemistry; Metallurgy 6 Active
US11965000B2 Respiratory syncytial virus (RSV) vaccine Chemistry; Metallurgy 5 Active
US11692002B2 RNA sequence adaptation Emerging Cross-Sectional Technologies 5 Active
US11739335B2 Nucleic acids encoding CRISPR-associated proteins and uses thereof Chemistry; Metallurgy 5 Active
US11690910B2 Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or peptide antigen Emerging Cross-Sectional Technologies 4 Active
US11697816B2 Artificial nucleic acid molecules Chemistry; Metallurgy 4 Active
US11872280B2 RNA vaccine against SARS-CoV-2 variants Chemistry; Metallurgy 4 Active
US11918643B2 RNA vaccine against SARS-CoV-2 variants Chemistry; Metallurgy 4 Active
US11723967B2 Zika virus vaccine Emerging Cross-Sectional Technologies 3 Active
US11761009B2 Artificial nucleic acid molecules for improved protein expression Emerging Cross-Sectional Technologies 3 Active
US11786590B2 Rotavirus vaccines Chemistry; Metallurgy 3 Active
US12097253B2 RSV RNA molecules and compositions for vaccination Chemistry; Metallurgy 1 Active
US12138348B2 Dry powder composition comprising long-chain RNA Human Necessities 1 Active
US12318486B2 Dry powder composition comprising long-chain RNA Human Necessities 1 Active
US12178863B2 Combination of vaccination and OX40 agonists Emerging Cross-Sectional Technologies 0 Active
US12194089B2 Coronavirus vaccine Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.